Lidocaine 0.4% and Dextrose 5%
Lidocaine 0.4% and Dextrose 5%, Hospira
4 mg/mL, 250 mL premixed bag (NDC 00409-7931-32)
4 mg/mL, 500 mL premixed bag (NDC 00409-7931-24)
Lidocaine 0.4% and Dextrose 5%, BBraun
4 mg/mL, 500 mL premixed bag (NDC 00264-9594-10)
Lidocaine 0.5%
Lidocaine 0.5%, Hospira
5 mg/mL, 50 mL SD Flip Top Vial (NDC 00409-4275-01)
Lidocaine 0.8% and Dextrose 5%
Lidocaine 0.8% and Dextrose 5%, Hospira
8 mg/mL, 250 mL premixed bag (NDC 00409-7939-32)
Lidocaine 1%
Xylocaine 1% - MPF injection, APP
10 mg/mL, 5 mL glass ampule (NDC 63323-0492-89)
Lidocaine 1% injection, Hospira
10 mg/mL, 5 mL Ansyr plastic emergency syringes (NDC 00409-9137-05)
Lidocaine 1.5%
Lidocaine 1.5% injection, Hospira
15 mg/mL, 20 mL sterile pack, glass ampule, preservative-free (NDC 00409-4056-01)
Lidocaine 2%
Lidocaine 2% injection, Amphastar IMS
20 mg/mL, 5 mL Luer-Jet emergency syringes (NDC 00548-3390-01)
Lidocaine 2% injection, APP
20 mg/mL, 5 mL SD Tear Top vial, preservative-free, (NDC 63323-0208-05)
Lidocaine 2% injection, Hospira
20 mg/mL, 5 mL Ansyr plastic emergency syringes (NDC 00409-1323-05)
Lidocaine 0.4% and Dextrose 5%
Lidocaine 0.4% and Dextrose 5%, BBraun
4 mg/mL, 250 mL premixed bag (NDC 00264-9594-20)
Lidocaine 0.4% and Dextrose 5%, Baxter
4 mg/mL, 500 mL premixed bag (NDC 00338-0409-03)
Lidocaine 0.5%
Lidocaine 0.5%, Hospira
5 mg/mL, 50 mL SD Tear Top Vial, preservative-free (NDC 00409-4278-01)
Xylocaine 0.5% injection, APP
5 mg/mL, 50 mL vial (NDC 63323-0484-57)
Xylocaine 0.5% - MPF injection, APP
5 mg/mL, 50 mL vial (NDC 63323-0491-57)
Lidocaine 0.8% and Dextrose 5%
Lidocaine 0.8% and Dextrose 5%, BBraun
8 mg/mL, 250 mL premixed bag (NDC 00264-9598-20)
Lidocaine 0.8% and Dextrose 5%, Baxter
8 mg/mL, 250 mL premixed bag (NDC 00338-0411-02)
Lidocaine 1%
Lidocaine 1% injection, Hospira
10 mg/mL, 5 mL preservative-free glass ampule (NDC 00409-4713-02)
10 mg/mL, 20 mL vial (NDC 00409-4276-01)
10 mg/mL, 30 mL preservative-free vial (NDC 00409-4279-02)
10 mg/mL, 2 mL preservative-free glass ampule (NDC 00409-4713-32)
10 mg/mL, 30 mL preservative-free vial, sterile pack (NDC 00409-4270-01)
10 mg/mL, 50 mL vial (NDC 00409-4276-02)
10 mg/mL, 5 mL LifeShield syringes (NDC 00409-4904-34)
Xylocaine 1% injection, APP
10 mg/mL, 20 mL vial (NDC 63323-0485-27)
10 mg/mL, 50 mL vial (NDC 63323-0485-57)
Lidocaine 1% injection, APP
10 mg/mL, 2 mL vial (NDC 63323-0201-02)
10 mg/mL, 10 mL vial (NDC 63323-0201-10)
Xylocaine 1% - MPF injection, APP
10 mg/mL, 2 mL glass ampule (NDC 63323-0492-80)
10 mg/mL, 2 mL vial (NDC 63323-0492-27)
10 mg/mL, 5 mL vial (NDC 63323-0492-57)
10 mg/mL, 30 mL vial, sterile pack (NDC 63323-0492-31)
10 mg/mL, 30 mL vial (NDC 63323-0492-37)
Lidocaine 1.5%
Lidocaine 1.5% injection, Hospira
15 mg/mL, 20 mL ampule, preservative-free (NDC 00409-4776-01)
Xylocaine 1.5% - MPF injection, APP
15 mg/mL, 10 mL ampule (NDC 63323-0493-97)
15 mg/mL, 20 mL ampule (NDC 63323-0493-91)
Lidocaine 2%
Lidocaine 2% injection, APP
20 mg/mL, 2 mL vial (NDC 63323-0202-02)
Xylocaine 2% injection, APP
20 mg/mL, 10 mL vial (NDC 63323-0486-17)
20 mg/mL, 20 mL vial (NDC 63323-0486-27)
20 mg/mL, 50 mL vial (NDC 63323-0486-57)
Xylocaine 2% - MPF injection, APP
20 mg/mL, 2 mL vial (NDC 63323-0495-27)
20 mg/mL, 5 mL vial (NDC 63323-0495-07)
20 mg/mL, 10 mL ampule (NDC 63323-0496-97)
Lidocaine 2% injection, Hospira
20 mg/mL, 2 mL glass ampule, preservative-free (NDC 00409-4282-01)
20 mg/mL, 5 mL vial, preservative-free (NDC 00409-2066-05)
20 mg/mL, 10 mL glass ampule, preservative-free (NDC 00409-4282-02)
20 mg/mL, 20 mL vial (NDC 00409-4277-01)
20 mg/mL, 50 mL vial (NDC 00409-4277-02)
20 mg/mL, 5 mL Lifeshield glass emergency syringes (NDC 00409-4903-34)
Lidocaine 4%
Xylocaine 4% injection, APP
40 mg/mL, 5 mL glass ampule, preservative-free (NDC 63323-0490-89)
Lidocaine 4% injection, Hospira
40 mg/mL, 5 mL glass ampule, preservative-free (NDC 00409-4283-01)
May 28, 2013; May 9, 2013; April 10, 2013; March 13, 2013; February 6, 2013; January 17, 2013; December 12, 2012; October 25, 2012; September 27, 2012; August 22, 2012; August 9, 2012; July 26, 2012; June 21, 2012; June 12, 2012; May 23, 2012; May 2, 2012; April 18, 2012; April 16, 2012; March 28, 2012; March 20, 2012; March 7, 2012; February 22, 2012; February 8, 2012; January 25, 2012; January 3, 2012; December 16, 2011; December 5, 2011; November 16, 2011, University of Utah, Drug Information Service. Copyright 2013, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.